Anti-MRSA Cephalosporin versus Vancomycin-Based Treatment for Acute Bacterial Skin and Skin Structure Infection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Anti-MRSA Cephalosporin versus Vancomycin-Based Treatment for Acute Bacterial Skin and Skin Structure Infection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

This systematic review and meta-analysis of randomized controlled trials (RCTs) compared the clinical efficacy and safety of anti-MRSA cephalosporin and vancomycin-based treatment in treating acute bacterial skin and skin structure infections (ABSSSIs). PubMed, Embase, Cochrane Central Register of C...

Full description

Bibliographic Details
Main Authors:	Ching-Yi Chen, Wang-Chun Chen, Chih-Cheng Lai, Tzu-Ping Shih, Hung-Jen Tang
Format:	Article
Language:	English
Published:	MDPI AG 2021-08-01
Series:	Antibiotics
Subjects:	acute bacterial skin and skin structure infection ceftaroline ceftobiprole vancomycin methicillin-resistant <i>Staphylococcus aureus</i>
Online Access:	https://www.mdpi.com/2079-6382/10/8/1020

Similar Items

Open-Label Randomized Trial of Early Clinical Outcomes of Ceftaroline Fosamil Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections at Risk of Methicillin-Resistant Staphylococcus aureus
by: Kimberly C. Claeys, et al.
Published: (2019-03-01)

Comparing the Outcomes of Ceftaroline plus Vancomycin or Daptomycin Combination Therapy versus Vancomycin or Daptomycin Monotherapy in Adults with Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia—A Meta-Analysis
by: Chienhsiu Huang, et al.
Published: (2022-08-01)

Ceftaroline in the treatment of methicillin-resistant and daptomycin-non-susceptible Staphylococcus aureus bacteremia and infective endocarditis in end-stage renal disease
by: Kristen Fuhrmann, et al.
Published: (2013-09-01)

New Antibiotics for the Treatment of Acute Bacterial Skin and Soft Tissue Infections in Pediatrics
by: Nicola Principi, et al.
Published: (2020-10-01)

Ceftobiprole for Treatment of MRSA Blood Stream Infection: A Case Series
by: Mahmoud E, et al.
Published: (2020-08-01)

Biofilm Formation in Methicillin-Resistant Staphylococcus aureus Isolated in Cystic Fibrosis Patients Is Strain-Dependent and Differentially Influenced by Antibiotics
by: Agathe Boudet, et al.
Published: (2021-10-01)

Seftarolin, Antibiotik Baru dengan Aktivitas Anti-MRSA: Sebuah Kajian Efektivitas, Keamanan, dan Biaya Penggunaan
by: Steven Victoria Halim, et al.
Published: (2020-03-01)

In Vitro Activities of Ceftobiprole, Dalbavancin, Tedizolid and Comparators against Clinical Isolates of Methicillin-Resistant <i>Staphylococcus aureus</i> Associated with Skin and Soft Tissue Infections
by: Sofia Maraki, et al.
Published: (2023-05-01)

Evaluation of the synergistic effect of ceftaroline against methicillin-resistant Staphylococcus aureus
by: Cheng-En Tsai, et al.
Published: (2022-09-01)

In Vitro Activity of Ceftaroline and Comparators against Bacterial Isolates Collected Globally from Patients with Skin and Soft Tissue Infections: ATLAS Program 2019–2020
by: Alona Kuraieva, et al.
Published: (2023-07-01)

Vancomycin and linear IgA bullous dermatosis
by: Amr Ismail, et al.
Published: (2018-01-01)

Pharmacodynamic comparison of different antimicrobial regimens against Staphylococcus aureus bloodstream infections with elevated vancomycin minimum inhibitory concentration
by: Thaina Miranda da Costa, et al.
Published: (2020-01-01)

Prevalence of Vancomycin Resistance in Methicillin-Resistant Staphylococcus Aureus
by: Parviz Mohajeri, et al.
Published: (2014-12-01)

Recent pattern of antibiotic resistance in Staphylococcus aureus clinical isolates in Eastern India and the emergence of reduced susceptibility to vancomycin
by: Srujana Mohanty, et al.
Published: (2019-10-01)

In vitro activity of ceftaroline and comparators against bacterial isolates collected globally from patients with skin infections
by: Denis Piérard, et al.
Published: (2021-09-01)

Methicillin and vancomycin resistant S. aureus in hospitalized patients
by: Poonam Sood Loomba, et al.
Published: (2010-01-01)

Identification and Characterization of Staphylococcus Aureus Methicillin and Vancomycin Resistance From Patients in Sari and Ghaemshahr Injuries and Burn Hospitals in 2015
by: Mohammad Movagharnezhad, et al.
Published: (2018-08-01)

Acute bacterial skin and skin structure infections: current perspective
by: Megha Shah, et al.
Published: (2011-01-01)

Emerging treatment options for acute bacterial skin and skin structure infections: focus on intravenous delafloxacin
by: Righi E, et al.
Published: (2018-04-01)

Bacterial Membrane-Derived Vesicles Attenuate Vancomycin Activity against Methicillin-Resistant <i>Staphylococcus aureus</i>
by: Monika Kumaraswamy, et al.
Published: (2021-09-01)

Vancomycin, linezolid and daptomycin susceptibility pattern among clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) from Sub- Himalyan Center
by: Afzal Husain, et al.
Published: (2018-04-01)

The Evaluation of Vancomycin and Daptomycin Susceptibility by E-Test Method in Methicillin-Resistant Staphylococcus aureus Isolates
by: Firdevs AKSOY, et al.
Published: (2012-03-01)

Efficacy and Safety of Daptomycin versus Vancomycin for Bacteremia Caused by Methicillin-Resistant <i>Staphylococcus</i> <i>aureus</i> with Vancomycin Minimum Inhibitory Concentration > 1 µg/mL: A Systematic Review and Meta-Analysis
by: Masaru Samura, et al.
Published: (2022-03-01)

In Vitro Activity Of Ceftaroline And Comparators Against Staphylococcus aureus Isolates: Results From 6 Years Of The ATLAS Program (2012 To 2017)
by: Zhang Z, et al.
Published: (2019-10-01)

Ceftaroline versus vancomycin for treatment of acute pulmonary exacerbations of cystic fibrosis in adults
by: Marc D. Esquivel, et al.
Published: (2022-03-01)

Vancomycin Resistance pattern of Staphylococcus aureus Isolated from Skin and Soft Tissue Infections (SSTI) in Mosul City
by: Muna M. Isaam
Published: (2009-06-01)

Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis
by: Ioanna Vlachaki, et al.
Published: (2021-10-01)

In vitro activity of ceftaroline: A novel antibiotic against methicillin-resistant Staphylococcus aureus
by: Vaishali Gaikwad, et al.
Published: (2016-01-01)

Comparative efficacy of linezolid and vancomycin for endotracheal tube MRSA biofilms from ICU patients
by: Laia Fernández-Barat, et al.
Published: (2019-07-01)

Ceft-to-Ceft Study: Real-Life Experience with Ceftaroline and Ceftobiprole in Treatment of the Principal Infectious Syndromes in a Spanish Multicenter Hospital Cohort
by: Daniel Arnés García, et al.
Published: (2023-12-01)

A Case Report of Staphylococcal Scalded Skin Syndrome with Toxic Shock Syndrome
by: Vaishali Kathuria, et al.
Published: (2020-04-01)

Investigation of the Minimal Inhibitory Concentration Values of Vancomycin, Teicoplanin and Linezolid among MRSA Isolated from Inpatients by E-test Method
by: Tuğrul HOŞBUL, et al.
Published: (2012-06-01)

Evaluating the antibacterial activity of ceftaroline against clinical isolates of methicillin-susceptible and- resistant Staphylococcus aureus in Kuwait hospitals
by: Wadha Alfouzan, et al.
Published: (2020-10-01)

Intermediate Vancomycin Susceptibility in a Community-associated MRSA Clone
by: Christopher J. Graber, et al.
Published: (2007-03-01)

Treatment Failure Outcomes for Emergency Department Patients with Skin and Soft Tissue Infections
by: Larissa S. May, et al.
Published: (2015-10-01)

Emergence of vancomycin-resistant Enterococcus faecium after use of inhaled vancomycin in a cystic fibrosis patient chronically infected with methicillin-resistant Staphylococcus aureus
by: Luiz Vicente Ribeiro Ferreira da Silva Filho, et al.
Published: (2008-09-01)

Alpha-amyrin as an anti-biofilm agent against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus
by: Pooi Yin Chung, et al.
Published: (2023-07-01)

Susceptibility of Clinical Isolates of Staphylococcus aureus to Ceftaroline
by: Harsha Sreedharan, et al.
Published: (2021-01-01)

Recovery of a 10-year-old girl from methicillin-resistant Staphylococcus aureus sepsis in response to low-dose ceftaroline treatment
by: Borgmann S, et al.
Published: (2016-05-01)

Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study
by: Samia Arshad, et al.
Published: (2017-04-01)